NCT02713607View on ClinicalTrials.gov

Lipidome and Microbiome Profile of Acne

PHASE1/PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

January 31, 2027

Study Completion Date

January 31, 2027

Conditions
Acne Vulgaris
Interventions
DRUG

Doxycycline

Given doxycycline to acne subjects

Trial Locations (1)

95816

UC Davis Dept of Dermatology, Sacramento

All Listed Sponsors
lead

University of California, Davis

OTHER

NCT02713607 - Lipidome and Microbiome Profile of Acne | Biotech Hunter | Biotech Hunter